Avidity Biosciences Stock Options
| RNA Stock | USD 30.08 0.76 2.46% |
Avidity Biosciences' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.15 with a put-to-call open interest ratio of 0.22 over 45 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on March 21st 2025.
Open Interest Against March 21st 2025 Option Contracts
2025-03-21
The chart above shows Avidity Biosciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Avidity Biosciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Avidity Biosciences' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Avidity Biosciences
Analyzing Avidity Biosciences' in-the-money options over time can help investors to take a profitable long position in Avidity Biosciences regardless of its overall volatility. This is especially true when Avidity Biosciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Avidity Biosciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Avidity Biosciences' stock while costing only a fraction of its price.
Avidity Biosciences' stock options are financial instruments that give investors the right to buy or sell shares of Avidity Biosciences common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Avidity stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Avidity Biosciences' stock price goes up or down, the stock options follow.
At present, Avidity Biosciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 1.3 B, whereas Common Stock is forecasted to decline to 6,840. Avidity Biosciences In The Money Call Balance
When Avidity Biosciences' strike price is surpassing the current stock price, the option contract against Avidity Biosciences stock is said to be in the money. When it comes to buying Avidity Biosciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Avidity Biosciences are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Avidity Current Options Market Mood
Avidity Biosciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Avidity Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Avidity Biosciences' options investors are not very successful. Avidity Biosciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Avidity contract
Base on the Rule 16, the options market is currently suggesting that Avidity Biosciences will have an average daily up or down price movement of about 0.0719% per day over the life of the 2025-03-21 option contract. With Avidity Biosciences trading at USD 30.08, that is roughly USD 0.0216. If you think that the market is fully incorporating Avidity Biosciences' daily price movement you should consider buying Avidity Biosciences options at the current volatility level of 1.15%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Avidity |
Purchasing Avidity Biosciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Avidity calls. Remember, the seller must deliver Avidity Biosciences stock to the call owner when a call is exercised.
Avidity Biosciences Option Chain
When Avidity Biosciences' strike price is surpassing the current stock price, the option contract against Avidity Biosciences stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Avidity Biosciences' option chain is a display of a range of information that helps investors for ways to trade options on Avidity. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Avidity. It also shows strike prices and maturity days for a Avidity Biosciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | RNA250321C00020000 | 3 | 20.0 | 9.0 - 13.5 | 12.32 | In |
Call | RNA250321C00026000 | 1 | 26.0 | 4.7 - 8.6 | 7.2 | In |
Call | RNA250321C00029000 | 3 | 29.0 | 3.5 - 6.4 | 5.4 | In |
Call | RNA250321C00030000 | 5 | 30.0 | 3.1 - 6.1 | 4.1 | Out |
Call | RNA250321C00032000 | 233 | 32.0 | 1.95 - 5.3 | 2.45 | Out |
Call | RNA250321C00034000 | 11 | 34.0 | 1.2 - 4.7 | 4.1 | Out |
Call | RNA250321C00035000 | 52 | 35.0 | 1.55 - 3.3 | 2.65 | Out |
Call | RNA250321C00038000 | 240 | 38.0 | 1.0 - 3.1 | 1.69 | Out |
Call | RNA250321C00039000 | 1 | 39.0 | 0.2 - 4.9 | 1.95 | Out |
Call | RNA250321C00040000 | 9 | 40.0 | 0.0 - 3.0 | 1.5 | Out |
Call | RNA250321C00041000 | 1 | 41.0 | 0.1 - 4.8 | 15.8 | Out |
Call | RNA250321C00042000 | 4 | 42.0 | 0.4 - 4.1 | 1.35 | Out |
Call | RNA250321C00043000 | 2 | 43.0 | 0.0 - 3.1 | 0.97 | Out |
Call | RNA250321C00044000 | 3 | 44.0 | 0.0 - 3.1 | 16.25 | Out |
Call | RNA250321C00045000 | 25 | 45.0 | 0.0 - 4.5 | 1.5 | Out |
Call | RNA250321C00046000 | 10 | 46.0 | 0.0 - 2.75 | 13.06 | Out |
Call | RNA250321C00047000 | 4 | 47.0 | 0.0 - 4.8 | 2.6 | Out |
Call | RNA250321C00048000 | 26 | 48.0 | 0.0 - 2.75 | 13.55 | Out |
Call | RNA250321C00049000 | 124 | 49.0 | 0.0 - 4.7 | 4.4 | Out |
Call | RNA250321C00050000 | 115 | 50.0 | 0.0 - 2.4 | 2.5 | Out |
Call | RNA250321C00055000 | 11 | 55.0 | 0.0 - 2.3 | 4.3 | Out |
Call | RNA250321C00060000 | 1 | 60.0 | 0.0 - 4.0 | 1.18 | Out |
Call | RNA250321C00065000 | 4 | 65.0 | 0.0 - 0.8 | 0.35 | Out |
Call | RNA250321C00070000 | 3 | 70.0 | 0.0 - 2.2 | 3.25 | Out |
Call | RNA250321C00075000 | 0 | 75.0 | 0.0 - 4.1 | 4.1 | |
Put | RNA250321P00025000 | 13 | 25.0 | 0.45 - 3.9 | 2.2 | Out |
Put | RNA250321P00026000 | 2 | 26.0 | 0.6 - 4.9 | 3.1 | Out |
Put | RNA250321P00030000 | 20 | 30.0 | 2.65 - 6.1 | 4.9 | Out |
Put | RNA250321P00031000 | 6 | 31.0 | 3.3 - 6.9 | 3.74 | In |
Put | RNA250321P00035000 | 1 | 35.0 | 6.0 - 9.3 | 6.0 | In |
Put | RNA250321P00039000 | 5 | 39.0 | 8.8 - 11.5 | 10.6 | In |
Put | RNA250321P00040000 | 30 | 40.0 | 9.3 - 13.3 | 12.2 | In |
Put | RNA250321P00041000 | 50 | 41.0 | 10.4 - 14.1 | 12.8 | In |
Put | RNA250321P00042000 | 6 | 42.0 | 11.1 - 14.9 | 6.8 | In |
Put | RNA250321P00043000 | 22 | 43.0 | 12.1 - 15.7 | 7.7 | In |
Put | RNA250321P00046000 | 0 | 46.0 | 14.5 - 18.5 | 14.5 | In |
Put | RNA250321P00047000 | 18 | 47.0 | 15.1 - 19.3 | 8.9 | In |
Put | RNA250321P00048000 | 14 | 48.0 | 16.6 - 20.3 | 13.1 | In |
Put | RNA250321P00049000 | 0 | 49.0 | 17.3 - 21.3 | 17.3 | In |
Put | RNA250321P00050000 | 5 | 50.0 | 18.1 - 22.2 | 18.5 | In |
Put | RNA250321P00055000 | 0 | 55.0 | 22.6 - 27.0 | 22.6 | In |
Put | RNA250321P00060000 | 0 | 60.0 | 27.5 - 32.0 | 27.5 | In |
Put | RNA250321P00065000 | 0 | 65.0 | 32.5 - 37.0 | 32.5 | In |
Put | RNA250321P00070000 | 0 | 70.0 | 37.5 - 42.0 | 37.5 | In |
Put | RNA250321P00075000 | 0 | 75.0 | 42.5 - 47.0 | 42.5 | In |
Avidity Total Stockholder Equity
Total Stockholder Equity |
|
Avidity Biosciences Corporate Management
| Kathleen Gallagher | Chief Officer | Profile | |
| Teresa McCarthy | Chief Officer | Profile | |
| Eric Mosbrooker | Chief Officer | Profile | |
| III JD | Consultant | Profile | |
| Michael CPA | Chief Officer | Profile | |
| Michael MacLean | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.88) | Revenue Per Share | Quarterly Revenue Growth (0.17) | Return On Assets | Return On Equity |
The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.